have been widely recognized as significant cardiac biomarkers, and are increasingly being recommended for early risk identification in cardiovascular high-risk populations. The aim of our study was to ...
The publisher has been vigilantly tracking the diverse markets within Saudi Arabia. This report presents an extensive analysis, encompassing market size, projections, emerging trends, factors driving ...
Anti-obesity drugs like tirzepatide and semaglutide show cardiovascular benefits beyond weight loss, with impacts on heart structure, bypass outcomes, and biomarkers in diabetes. New studies in JACC ...